Abstract

To explore the influence of bilateral subthalamic deep brain stimulation (STN-DBS) on car driving ability in patients with Parkinson’s disease (PD), we prospectively examined two age-matched, actively driving PD patient groups: one group undergone DBS-surgery (PD-DBS, n = 23) and one group that was eligible for DBS but did not undergo surgery (PD-nDBS, n = 29). In PD-DBS patients, investigation at Baseline was done just prior and at Follow-up 6–12 month after DBS-surgery. In PD-nDBS patients, time interval between Baseline and Follow-up was aimed to be comparable. To assess the general PD driving level, driving was assessed once in 33 age-matched healthy controls at Baseline. As results, clinical and driving characteristics of PD-DBS, PD-nDBS and controls did not differ at Baseline. At Follow-up, PD-DBS patients drove unsafer than PD-nDBS patients. This effect was strongly driven by two single PD-DBS participants (9%) with poor Baseline and disastrous Follow-up driving performance. Retrospectively, we could not identify any of the assessed motor and non-motor clinical Baseline characteristics as predictive for this driving-deterioration at Follow-up. Excluding these two outliers, comparable driving performance between PD-DBS and PD-nDBS patients not only at Baseline but also at Follow-up was demonstrated. Age, disease duration and severity as well as Baseline driving insecurity were associated with poorer driving performance at Follow-up. This first prospective study on driving safety in PD after DBS surgery indicates that DBS usually does not alter driving safety but might increase the risk for driving deterioration, especially in single subjects with already unsafe driving prior to DBS surgery.

Details

Title
Prospective controlled study on the effects of deep brain stimulation on driving in Parkinson’s disease
Author
Fründt, Odette 1 ; Mainka, Tina 2 ; Vettorazzi, Eik 3   VIAFID ORCID Logo  ; Baspinar, Ela 4 ; Schwarz, Cindy 4 ; Südmeyer, Martin 5 ; Gerloff, Christian 4 ; Zangemeister, Wolfgang H. 4 ; Poetter-Nerger, Monika 4   VIAFID ORCID Logo  ; Hidding, Ute 4 ; Hamel, Wolfgang 6 ; Moll, Christian K. E. 7 ; Buhmann, Carsten 4   VIAFID ORCID Logo 

 University Medical Center Hamburg-Eppendorf, Department of Neurology, Hamburg, Germany (GRID:grid.13648.38) (ISNI:0000 0001 2180 3484); Ernst von Bergmann Clinic, Department of Neurology, Potsdam, Germany (GRID:grid.13648.38) 
 University Medical Center Hamburg-Eppendorf, Department of Neurology, Hamburg, Germany (GRID:grid.13648.38) (ISNI:0000 0001 2180 3484); Charité Campus Mitte, Department of Neurology with Experimental Neurology, Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662); Berlin Institute of Health at Charité Universitätsmedizin Berlin, BIH Charité Clinician Scientist Program, Berlin, Germany (GRID:grid.484013.a) (ISNI:0000 0004 6879 971X) 
 University Medical Center Hamburg-Eppendorf, Department of Medical Biometry and Epidemiology, Hamburg, Germany (GRID:grid.13648.38) (ISNI:0000 0001 2180 3484) 
 University Medical Center Hamburg-Eppendorf, Department of Neurology, Hamburg, Germany (GRID:grid.13648.38) (ISNI:0000 0001 2180 3484) 
 Ernst von Bergmann Clinic, Department of Neurology, Potsdam, Germany (GRID:grid.13648.38) 
 University-Hospital Hamburg-Eppendorf, Department of Neurosurgery, Hamburg, Germany (GRID:grid.13648.38) (ISNI:0000 0001 2180 3484) 
 University-Hospital Hamburg-Eppendorf, Institute of Neurophysiology and Pathophysiology, Hamburg, Germany (GRID:grid.13648.38) (ISNI:0000 0001 2180 3484) 
Pages
105
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
23738057
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2832169482
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.